The global benefit that put fertility care - IVF, egg freezing, adoption, surrogacy, menopause - inside the employee handbook.
CARROT FERTILITY, INC. — Menlo Park, California.
The wordmark of a company built to make family-building a benefit, not a bill.
Carrot Fertility is a global fertility and family-building benefit that employers and health plans buy for their people. It is not sold to individuals directly - you get Carrot because your employer offers it.
The idea started with an invoice. Co-founder Tammy Sun was quoted roughly $35,000 to freeze her eggs, out of pocket, and realized the fertility system was built to confuse rather than support. In 2016 she teamed with reproductive endocrinologist Dr. Asima Ahmad, Juli Insinger and Arun Venkatesan to turn that frustration into a benefit companies could offer.
Carrot covers the full arc of family-building: fertility preservation like egg and sperm freezing, assisted reproduction such as IVF and IUI, pregnancy and postpartum care, adoption and gestational surrogacy, plus low-testosterone care and menopause support. An employer designates funds; Carrot handles the administration, the clinical guidance and the payments.
Crucially, Carrot is guidance-first. About 60% of members choose an option less invasive and less expensive than IVF - because the Care Team helps them find the right path rather than defaulting to the priciest one. That is the difference between a benefit that spends money and one that manages it.
Coverage travels. Carrot supports members in more than 195 countries with a global provider network, localized resources and best-in-class language support, all tied together by the Carrot Card payment platform. For a distributed, global workforce, that reach is the product.
Carrot's customers are employers and health plans of every size; its members are the covered employees and their partners.
The core employer-sponsored benefit spanning fertility preservation, IVF, IUI, pregnancy, adoption, surrogacy, low-T and menopause. Flexible plan designs: a customizable dollar maximum or a cycle-based number of treatment rounds.
Lets members pay providers directly for eligible care while employers fund the benefit and Carrot manages administration and compliance - the rail that makes global reimbursement work.
Fertility medication often priced 50%+ below typical IVF drug costs. A newer Flex Program extends further savings to US employers.
Expert-led guidance plus a vetted global provider network, localized resources and multilingual support across 195+ countries.
Addresses metabolic causes behind some fertility challenges - part of Carrot's push into hormonal and metabolic health.
“Provide access to fertility care and family-building support - for everyone, everywhere.”
Carrot competes in a fast-growing fertility-benefits category alongside Progyny, Maven Clinic and Kindbody. Its wedge is breadth and reach: a whole-journey model from pre-pregnancy through menopause, delivered globally, priced on measurable outcomes.
Where Progyny centers on US clinical networks and Maven positions as a broad virtual women's-and-family clinic, Carrot pairs the Carrot Card payment rail with Carrot Rx savings and a 195+ country footprint. It sells HR on data - engagement, cost savings, clinical outcomes - not just generosity.
The guidance-first result is telling: most members choose something other than IVF, which keeps costs down for employees and employers alike.
Figures per Carrot public materials; reach and savings are approximate.
B2B2C. Carrot sells fertility benefits to employers and health plans on a subscription and administration basis. Employers designate funds; members spend via the Carrot Card. Carrot earns through platform and administration fees plus pharmacy (Carrot Rx). Members must be enrolled through an employer or plan to use it.
Fertility benefits have moved from perk to retention lever, and coverage has climbed sharply in recent years. Carrot sits at the global, whole-journey end of the shelf - competing with Progyny, Maven and Kindbody for the same HR budget, and betting that the winner is whoever employers renew.
Tammy Sun, Dr. Asima Ahmad, Juli Insinger and Arun Venkatesan set out to fix a broken fertility-benefits system.
SoftTech VC and Precursor Ventures back the earliest platform; year one is spent educating HR leaders.
U.S. Venture Partners leads a raise to scale amid growing employer demand for fertility coverage.
Tiger Global leads a round that pushes total funding past $114M and funds global expansion.
Carrot launches a metabolic-fertility program and expands payment options across the US.
CEO Tammy Sun joins a White House discussion on expanding fertility and maternal-health access.
CEO. Former head of partnerships at Evernote; started Carrot after a five-figure egg-freezing bill.
Chief Medical Officer. Reproductive endocrinologist anchoring Carrot's clinical model.
Co-founding operator who helped shape Carrot's early benefit design and go-to-market.
Co-founder contributing to Carrot's product and technology foundation.
It provides employer- and health-plan-sponsored fertility and family-building benefits - egg freezing, IVF, IUI, adoption, surrogacy, pregnancy support, low-testosterone care and menopause - backed by an expert Care Team and a global provider network.
Carrot is not sold to individuals. You access it if your employer or health plan offers it; the employer designates funds and members pay providers with the Carrot Card.
Founded in 2016 by Tammy Sun, Dr. Asima Ahmad, Juli Insinger and Arun Venkatesan. Sun is CEO; Ahmad is Chief Medical Officer.
Carrot emphasizes a global, whole-journey model across 195+ countries with the Carrot Card and Carrot Rx savings, while Progyny centers on US clinical networks and Maven positions as a broad virtual women's and family health clinic.
Roughly $114M+ total across seed through Series C, including a $75M Series C led by Tiger Global in 2021.